Jefferies Group LLC Biogen Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$194.69 - $268.46 $22.6 Million - $31.2 Million	116,100 Added 165.86%	186,100 $49.7 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $22.6 Million - $31.2 Million	116,100 Added 165.86%	186,100 $49.7 Million
Q2 2022 Sep 21, 2023	BUY	$187.54 - $223.02 $8.44 Million - $10 Million	45,000 Added 180.0%	70,000 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $8.44 Million - $10 Million	45,000 Added 180.0%	70,000 $14.3 Million
Q1 2022 Sep 21, 2023	BUY	$193.77 - $244.14 $3.86 Million - $4.86 Million	19,900 Added 390.2%	25,000 $5.27 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $3.86 Million - $4.86 Million	19,900 Added 390.2%	25,000 $5.27 Million
Q4 2021 Sep 21, 2023	SELL	$223.92 - $287.77 $1.1 Million - $1.41 Million	-4,900 Reduced 49.0%	5,100 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $1.1 Million - $1.41 Million	-4,900 Reduced 49.0%	5,100 $1.22 Million
Q3 2021 Sep 21, 2023	SELL	$282.99 - $369.05 $1.13 Million - $1.48 Million	-4,000 Reduced 28.57%	10,000 $2.83 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $1.13 Million - $1.48 Million	-4,000 Reduced 28.57%	10,000 $2.83 Million
Q2 2021 Sep 21, 2023	SELL	$259.0 - $414.71 $21.9 Million - $35 Million	-84,400 Reduced 85.77%	14,000 $4.85 Million
Q2 2021 Aug 20, 2021	SELL	$259.0 - $414.71 $359 Million - $575 Million	-1,386,000 Reduced 99.0%	14,000 $4.85 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $337 Million - $540 Million	1,301,600 Added 1322.76%	1,400,000 $4.85 Million
Q1 2021 Sep 21, 2023	BUY	$242.95 - $284.63 $18.2 Million - $21.4 Million	75,100 Added 322.32%	98,400 $27.5 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $18.2 Million - $21.4 Million	75,100 Added 322.32%	98,400 $27.5 Million
Q4 2020 Sep 21, 2023	SELL	$236.26 - $355.63 $38.5 Million - $57.9 Million	-162,800 Reduced 87.48%	23,300 $5.71 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $3.52 Million - $5.3 Million	14,900 Added 177.38%	23,300 $5.71 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $19.5 Million - $25.8 Million	-75,300 Reduced 89.96%	8,400 $2.25 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $14.9 Million - $18.9 Million	55,400 Added 195.76%	83,700 $26.5 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $7.44 Million - $10.3 Million	-33,800 Reduced 54.43%	28,300 $8.4 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $16 Million - $18 Million	-73,700 Reduced 54.27%	62,100 $14.5 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $6.78 Million - $7.47 Million	-30,900 Reduced 18.54%	135,800 $31.8 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $31.6 Million - $49.5 Million	145,900 Added 701.44%	166,700 $39.4 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $194,950 - $246,925	-700 Reduced 3.26%	20,800 $6.26 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $5.08 Million - $6.64 Million	17,300 Added 411.9%	21,500 $7.6 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $11.6 Million - $13.8 Million	-45,100 Reduced 91.48%	4,200 $1.22 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $12 Million - $17 Million	46,200 Added 1490.32%	49,300 $13.5 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $2.71 Million - $3.03 Million	-8,800 Reduced 73.95%	3,100 $988,000
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $3.35 Million - $3.92 Million	11,900	11,900 $3.73 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account